Use of molecular assays for the diagnosis of influenza

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 1, 2007, Pages 89-104

  Vernet, Guy ^a  

^a BIOMÉRIEUX   (France)

Author keywords

Identification; Influenza; Molecular diagnostics; Respiratory viruses; Typing

Indexed keywords

ADAMANTANE; ALPHA INTERFERON; AMANTADINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; OSELTAMIVIR; PEGINTERFERON; PROTEINASE INHIBITOR; SIALIDASE INHIBITOR; ZANAMIVIR;

BACTERIAL STRAIN; CHROMATOGRAPHY; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; DISEASE SEVERITY; DISEASE SURVEILLANCE; DNA DETERMINATION; DNA MICROARRAY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GENETIC SCREENING; HUMAN; IMMUNOFLUORESCENCE TEST; INFLUENZA; INFLUENZA VIRUS A; INFRARED SPECTROMETRY; LABORATORY DIAGNOSIS; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOLECULAR EPIDEMIOLOGY; MORTALITY; NONHUMAN; PANDEMIC; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; SEPTICEMIA; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; THERAPEUTIC ERROR; TISSUE CULTURE; UNSPECIFIED SIDE EFFECT; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TYPING; ANIMAL; GENETIC PROCEDURES; GENETICS; VIROLOGY;

ANIMALS; GENETIC TECHNIQUES; HUMANS; INFLUENZA, HUMAN;

EID: 33947726845     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.1.89     Document Type: Review

References (102)

1. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 87, 1944-1950 (1997).
2. Monto A, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch. Intern. Med. 160, 3243-3247 (2000).
3. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin. Infect. Dis. 31, 1166-1169 (2000).
4. Aguilera JF, Paget WJ, Mosnier A et al. Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur. J. Epidemiol. 18, 733-736 (2003).
5. Keech M, Scott AJ, Ryan PJJ. The impact of influenza like illness on productivity and healthcare resource utilization in a working population. Occup. Med. 48, 85-90 (1998).
6. Moscona A. Neuraminidase inhibitors for influenza. N. Engl J. Med. 353, 1363-1373 (2005).
7. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Thehnology Assesment 7, 1-170 (2003).
8. Langley JM, Faughnan ME. Prevention of influenza in the general population. Can. Med. Assoc. J. 171, 1213-1222 (2004).
9. Stöhr K. Preventing and treating influenza. Br. Med. J. 326, 1223-1224 (2003).
10. Rothberg MB, Shunian H, Rose DN. Management of influenza symptoms in healthy adults: cost-effectiveness of rapid testing and antiviral therapy. J. Gen. Intern. Med. 18, 808-815 (2003).
11. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann. Intern. Med. 139, 321-329 (2003).
12. Hueston WJ, Benich JJ III. A cost-benefit analysis of testing for influenza A in high-risk adults. Ann. Family Med. 2, 33-40 (2004).
13. Lim S, Richardson D, Conly J. Influenza and the new antivirals: potential for misdiagnosis and possible misuse of antivirals. Can. Commun. Dis. Rep. 26, 202-205 (2000).
14. Lye DC, Nguyen DH, Giriputro S, Anekthananon T. Eraksoy H, Tambyah PA. Practical management of avian influenza in humans. Singapore Med. J. 47, 471-475 (2006).
15. Weinberg A, Walker M. Evaluation of three influenza A and B rapid antigen detection kits. Clin. Diagn. Lab. Immunol. 12, 367-370 (2005).
16. van Riel D, Munster VJ, de Wit E et al. H5N1 virus attachment to lower respiratory tract. Science 312, 399 (2006).
17. Peiris JS. Severe acute respiratory syndrome. J. Clin. Virol. 28, 245-247 (2003).
18. Meerhoff TJ, Meijer A, Paget WJ. Methods for sentinel virological surveillance of influenza in Europe - an 18-country survey. Eurosurveillance 9, 34-38 (2004).
19. Ellis JS, Fleming DM, Zambon MC. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J. Clin. Microbiol. 35, 2076-2082 (1997).
20. Petrich A, Mahony J, Chong S et al. Multicenter comparison of nucleic acid extraction methods for detection of severe acute respiratory syndrome coronavirus RNA in stool specimens. J. Clin. Microbiol. 44, 2681-2688 (2006).
21. Hill CS. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev. Mol. Diagn. 1, 445-455 (2001).
22. Deiman B, van Aarle P, Sillekens P. Characteristics and applications of nucleic acid sequence-based amplification (NASBA). Mol. Biotechnol. 20, 163-179 (2002).
23. McClernon DR, Vavro C, St Clair M. Evaluation of a real-time nucleic acid sequence-based amplification assay using molecular beacons for detection of human immunodeficiency virus type 1. J. Clin. Microbiol. 44, 2280-2282 (2006).
24. Landry ML, Garner R. Ferguson D. Real-time nucleic acid sequence-based amplification using molecular beacons for detection of enterovirus RNA in clinical specimens. J. Clin. Microbiol. 43, 3136-3139 (2005).
25. Moore C, Valappil M, Corden S, Westmoreland D. Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples. Eur. J. Clin. Microbiol. Infect. Dis. 25, 167-74 (2006).
26. Keightley MC, Sillekens P, Schippers W, Rinaldo C, George KS. Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR. J. Med. Virol. 77, 602-608 (2005).
27. Moore C, Hibbitts S, Owen N et al. Development and evaluation of a real-time nucleic acid sequence based amplification assay for rapid detection of influenza A. J. Med. Virol. 74, 619-628 (2004).
28. Loens K, Goossens H, de Laat C et al. Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season. J. Clin. Microbiol. 44, 166-171 (2006).
29. Loens K, Beck T, Goossens H et al. Development of conventional and realtime NASBA(R) for the detection of Legionella species in respiratory specimens. J. Microbiol. Methods 25, (2006) (Epub ahead of print).
30. Loens K, Beck T, Ursi D, Pattyn S, Goossens H, Ieven M. Two quality control exercises involving nucleic acid amplification methods for detection of Myroplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004). J. Clin. Microbiol. 44, 899-908 (2006).
31. Hibbitts S, Rahman A, John R, Westmoreland D, Fox JD. Development and evaluation of NucliSens basic kit NASBA for diagnosis of parainfluenza virus infection with 'end-point' and 'real-time' detection. J. Virol. Methods 108, 145-155 (2003).
32. Yates S, Penning M, Goudsmit J et al. Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection. J. Clin. Microbiol. 39, 3656-3665 (2001).
33. Mackay IM, Arden KE, Nitsche A. Rea-time PCR in virology. Nucleic Acids Res. 30, 1292-305 (2002).
34. Vernet G. Molecular diagnostics in virology. J. Clin. Virol. 31, 239-247 (2004).
35. Clewley JP. A role for arrays in clinical virology: fact or fiction? J. Clin. Virol. 29, 2-12 (2004).
36. An HJ, Cho NH, Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97, 1672-1680 (2003).
37. Ghindilis AL, Smith MW, Schwarzkopf KR et al. CombiMatrix oligonucleotide arrays: genotyping and gene expression assays employing electrochemical detection. Biosens. Bioelectron. DOI: 10.1016/ j.bios.2006.06.024 (2006) (Epub ahead of print).
38. Korimbocus J, Scaramozzino N, Lacroix B, Crance JM, Garin D, Vernet G. DNA probe array for the simultaneous identification of herpesviruses, enteroviruses, and flaviviruses. J. Clin. Microbiol. 43, 3779-3787 (2005).
39. Gonzalez R, Masquelier B, Fleury H et al. Detection of HIV-1 antiretroviral resistance mutations with high-density DNA probe arrays. J. Clin. Microbiol. 42, 2907-2912 (2004).
40. Tran N, Berne R, Chann R et al. European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis virus resistance mutations and identification of genotypes. J. Clin. Microbiol. 44, 2792-2800 (2006).
41. Briese T, Palacios G, Kokoris M et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg. Infect. Dis. 11, 310-313 (2005).
42. Mahony J, Chong S, Merante F et al. Development of a multiplex nucleic acid amplification assay for the detection and identification of 17 human respiratory viruses. Presented at: American Society of Microbiology FL, USA. May 21-25, 2006.
43. Han J, Swan DC, Smith SJ et al. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J. Clin. Microbiol. 44, 4157-4162 (2006).
44. Brunstein J, Thomas E. Direct screening of clinical specimens for multiple respiratory pathogens using the Genaco Respiratory Panels 1 and 2. Diagn. Mol. Pathol. 15, 169-173 (2006).
45. Gunson RN, Collins TC, Carman WF. Practical experience of high throughput real time PCR in the routine diagnostic virology setting. J. Clin. Virol. 35, 355-367 (2006).
46. Gruteke P, Glas AS, Dierdop M, Vreede WB, Pilon JW, Bruisten S. Practical implementation of a multiplex PCR for acute respiratory tract infections in children. J. Clin. Microb. 42, 5596-5603 (2004).
47. Lin B, Wang Z, Vora GJ et al. Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. Genome Res. 16, 527-535 (2006).
48. Wang D, Coscoy L, Zylberberg M et al. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. USA 99, 15687-15692 (2002).
49. Wang D, Urisman A, Liu YT et al. Viral discovery and sequence recovery using DNA microarrays. PloS Biol. 1, E2 (2003).
50. Hindiyeh M, Levy V, Azar R et al. Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel. J. Clin. Microbiol. 43, 589-595 (2005).
51. Smith AB, Mock V, Melear R. Colarusso P, Willis DE. Rapid detection of influenza A and B viruses in clinical specimens by Light Cycler real time RT-PCR. J. Clin. Virol. 28, 51-58 (2003).
52. van Elden LJR, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 39, 196-200 (2001).
53. Habib-bein NF, Beckwith WH III, Mayo D, Landry ML. Comparison of SmartCycler real-time reverse transcription-PCR assay in a public health laboratory with direct immunofluorescence and cell culture assays in a medical center for detection of influenza A virus. J. Clin. Microbiol. 41, 3597-3601 (2003).
54. Telles JN, Billaud G, Lefeuvre A et al. Evaluation of a real-time NASBA assay for the detection of Influenza A and B viruses in clinical respiratory samples. 15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen, Denmark, April 2-5, 2005.
55. Di Trani L, Bedini B, Donatelli I et al. A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control. BMC Infect. Dis. 6, 87-94 (2006).
56. Spackman E, Senne DA, Myers TJ et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40, 3256-3260 (2002).
57. Cattoli G, Drago A, Maniero S et al. Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol. 33, 432-437 (2004).
58. Chaharaein B, Omar AR, Aini I, Yusoff K, Hassan SS. Reverse transcriptase-polymerase chain reaction-enzyme linked immunosorbent assay for rapid detection of avian influenza virus subtype H9N2. Arch. Virol. (2006) (Epub ahead of print).
59. Xie Z, Pang YS, Liu J et al. A multiplex RT-PCR for detection of type A influenza virus and differentiation of avian H5, H7 and H9 hemagglutinin subtypes. Mol. Cell Probes 20, 245-249 (2006).
60. Fouchier RA, Schneeberger PM, Rozendaal FW et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. USA 101, 1356-1361 (2004).
61. Ng LF, Barr I, Nguyen T et al. Specific detection of H5N1 avian influenza virus in field specimens by a one-step RT-PCR assay. BMC Infect. Dis. 6, 40 (2006).
62. Lau LT, Banks J, Aherne R et al. Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem. Biophys. Res. Commun. 313, 336-342 (2004).
63. Vernet G. The use of real-time NASBA for the diagnosis of H5N1 Influenza and other respiratory viruses. First International Conference on Avian Influenza in Humans: latest advances on prevention, therapies and protective measures. Paris, France. June 29-30, 2006.
64. van den Hoogen BG, de Jong JC et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 6, 719-24 (2001).
65. van der Hoek L, Pyrc K, Jebbink MF et al. Identification of a new human coronavirus. Nat. Med. 10, 368-73 (2004).
66. Woo PC, Lau SK, Chu CM et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79, 884-95 (2005).
67. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl Acad. Sci. USA 102, 12891-12896 (2005).
68. Drosten CS, Gunther W, Preiser S et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl J. Med. 348, 1967-1976 (2003).
69. File TM. Community-acquired pneumonia. Lancet 362, 1991-2001 (2003).
70. Fine MJ, Stone RA, Singer DE et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch. Intern. Med. 159, 970-980 (1999).
71. Garbino J. Gerbase MW, Wunderli W et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am. J. Respir. Crit. Care Med. 170, 1197-1203 (2004).
72. Barenfanger J, Drake C, Leon N, Mueller T, Troutt T. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study J. Clin. Microbiol. 38, 2824-2828 (2000).
73. Woo P, Chiu S, Seto WH, Peiris M. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J. Clin. Microbiol. 35, 1579-1581 (1997).
74. De Clercq E. Recent highlights in the development of new antiviral drugs. Curr. Opin. Microbiol. 8, 552-560 (2005).
75. De Clercq E. Hope and hype. Nat. Med. 12, 727(2006).
76. Paeshuyse J, Leyssen P, Mabery E et al. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J. Virol. 80, 149-160 (2006).
77. Stittelaar KJ, Neyts J, Naesens L et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 9, 745-748 (2006).
78. Smith R, Openshaw P. Bronchiolitis. Lancet 368, 312-322 (2006).
79. Abed Y, Boivin G. Treatment of respiratory virus infections. Antiviral Res. 70, 1-16 (2006).
80. Haagmans BL, Osterhaus AD. Coronaviruses and their therapy. Antiviral Res. 71, 397-403 (2006).
81. Dolan S, Robinson C, Lehr M. Respiratory season 2005-2006 are we ready? Contagious Comments XX(7), 1-6 (2005).
82. Van Elden LJ, van Kraaji MG, Nijhuis M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin. Infect. Dis. 34, 177-183 (2002).
83. Weinberg A, Zamora MR, Li S, Toerres F, Hodges TN. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J. Clin. Virol. 25, 171-175 (2002).
84. Weinberg GA, Erdmann DD, Edwards KM et al. New vaccine surveillance network study group. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J. Infect. Dis 189, 706-710 (2004).
85. Watzinger F, Suda M, Preuner S et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J. Clin. Microbiol. 42, 5189-5198 (2004).
86. Legoff J, Guerot E, Ndjoyi-Mbiguino A et al. High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assays. J. Clin. Microbiol. 43, 455-457 (2005).
87. Erdman DD, Weinberg GA, Edwards KM et al. GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J. Clin. Microbiol. 41, 4298-4303 (2003).
88. Coyle PV, Ong GM, O'Neill HJ et al. A touchdown nucleic acid amplification protocol as an alternative to culture backup for immunofluorescence in the routine diagnosis of acute viral respiratory tract infections. BMC Microbiol. 4, 41-50 (2004).
89. Templeton KE, Sitha A, Scheltinga A, Beersma MFC, Kroes ACM, Claas ECJ. Improved diagnosis of the aetiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin. Infect. Dis. 41, 345-351 (2005).
90. Liolos L, Jenney A, Spelman D, Kotsimbos T, Catton M, Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J. Clin. Microb. 39, 2779-2783 (2001).
91. Coiras MT, Lopez-Huertas MR, Lopez-Campos G, Aguilar JC, Perez-Brena P. Oligonucleotide array for simultaneous detection of respiratory viruses using a reverse-line blot hybridization assay. J. Med. Virol. 76, 256-264 (2005).
92. Templeton KE, Forde CB, van Loon AM et al. A multi-center pilot proficiency programme to assess the quality of molecular detection of respiratory viruses. J. Clin. Virol. 35, 51-58 (2006).
93. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. In: Options for the Control of Influenza IV. Osterhaus ADME, Cox N, Hampson AW (Eds). Elsevier Science, Amsterdam, The Netherlands 103-106 (2001).
94. Berger A, Drosten Ch, Doerr HW, Sturmer M, Preiser W. Severe acute respiratory syndrome (SARS) - paradigm of an emerging viral infection. J. Clin. Virol. 29, 13-22 (2004).
95. Smith GJ, Naipospos TS, Nguyen TD et al. Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology 350, 258-268 (2006).
96. Choi YK, Ozaki H, Webby RJ et al. Continuing evolution of H9N2 influenza viruses in Southeastern China. J. Virol. 78, 8609-8614 (2004).
97. Dundon WG, Milani A, Cattoli G, Capua I. Progressive truncation of the non-structural 1 gene of H7N1 avian influenza viruses following extensive circulation in poultry. Virus Res. 119. 171-176 (2006).
98. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 320, 258-266 (2004).
99. Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H. Sugaya N, Kawaoka Y. High frequency of resistant viruses harbouring different mutations in amantadine-treated children with influenza. J. Infect. Dis. 188, 57-61 (2003).
100. Kessler N, Ferraris O, Palmer K, Marsh W, Steel A. Use of the DNA flow-thru chip, a three-dimensional blochip, for typing and subtyping of influenza viruses. J. Clin. Microbiol. 42, 2173-2185 (2004).
101. Townsend MB, Dawson ED, Mehlmann M et al. Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J. Clin. Microbiol. 44, 2863-2871 (2006).
102. Mehlman M, Dawson ED, Townsend MB et al. Robust sequence selection method used to develop the FluChip diagnostic microarray for influenza virus. J. Clin. Microbiol. 44, 2857-2862 (2006).